Aditya Humad, the former CFO of the Massachusetts-based medical device firm SpineFrontier, was sentenced to four months in federal prison and ordered to pay a $9,500 fine. The sentencing follows a legal case initiated in September 2021, which also involved the company’s founder, president, and CEO, Kingsley R. Chin.

According to federal prosecutors, Humad was involved in a long-running scheme to pay illegal kickbacks to surgeons. These payments were allegedly disguised as consulting fees or other legitimate business expenses, but were intended to induce the surgeons to use SpineFrontier’s spinal implants and instruments in their medical procedures. The case highlighted concerns regarding the influence of financial incentives on medical decision-making and the integrity of the healthcare supply chain.

While the legal proceedings against Humad have concluded with this sentencing, the broader implications for SpineFrontier and the other individuals named in the 2021 charges remain a subject of ongoing interest. The court’s decision to impose both prison time and a financial penalty reflects the severity with which the judicial system treats corporate fraud and healthcare-related bribery. The case serves as a reminder of the strict regulations governing the relationship between medical device manufacturers and the physicians who utilize their products.